<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00799812</url>
  </required_header>
  <id_info>
    <org_study_id>ENT 371-121</org_study_id>
    <nct_id>NCT00799812</nct_id>
  </id_info>
  <brief_title>Test for Preoperative Skin Preparations</brief_title>
  <official_title>ChloraPrep Triple Swabsticks, Hibiclens and Sterile Triple Swabsticks (Using Sterile Deionized Water)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CareFusion</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CareFusion</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Compare 2 application techniques of ChloraPrep Swabstick--3 swabsticks at once versus 3
      swabsticks used one-at-a-time. Hibiclens applied according to the manufacturer's directions.
      Sterile swabsticks (wetted with sterile water) applied using the same method as the
      ChloraPrep Swabstick.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Determine differences (if any)in 2 different application techniques of ChloraPrep
      Swabstick--3 swabsticks at once versus 3 swabsticks used one-at-a-time. Hibiclens, a liquid
      antibacterial soap, applied according to the manufacturer's directions as a active/positive
      comparison. Sterile swabsticks (wetted with sterile water) applied as a negative comparison
      using the same method as the ChloraPrep swabstick.

      Study uses topical sampling from the abdomen and the groin on intact skin and evaluate the
      germs left on the skin after treatment with ChloraPrep Swabsticks.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2007</start_date>
  <completion_date type="Actual">April 2008</completion_date>
  <primary_completion_date type="Actual">April 2008</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Determine differences in log reductions in CFU/cm2 on inguinal and abdominal sites when using 2 different application techniques</measure>
    <time_frame>10 minutes and 6 hours after application of test solutions</time_frame>
  </primary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">111</enrollment>
  <condition>Topical Antisepsis</condition>
  <arm_group>
    <arm_group_label>CHG Swabstick (3 @ once)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Chlorhexidine(CHG)2% CHG/isopropyl alcohol (IPA)70%-3 swabsticks applied @ same time</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CHG Swabstick sequential</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Chlorhexidine gluconate 2% w/v and isopropyl alcohol 70% v/v--3 swabsticks applied one-at-a-time</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hibiclens</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Chlorhexidine gluconate 4% w/v in an aqueous base</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sterile water swab (3 @ once)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Sterile swabstick wetted with sterile water--3 swabsticks applied at the same time.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sterile water swabstick (sequential)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Sterile swabstick wetted with sterile water--3 swabsticks applied one-at-a-time.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>CHG 2% w/v &amp; IPA 70% v/v, swabstick (3 @ once).</intervention_name>
    <description>3 swabsticks topically applied at the same time to intact skin</description>
    <arm_group_label>CHG Swabstick (3 @ once)</arm_group_label>
    <other_name>ChloraPrep Swabstick</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>CHG 2% w/v &amp; IPA 70% v/v swab applied sequentially</intervention_name>
    <description>Chlorhexidine gluconate 2% w/v and isopropyl alcohol 70% v/v; 3 swabsticks applied sequentially to intact skin.</description>
    <arm_group_label>CHG Swabstick sequential</arm_group_label>
    <other_name>ChloraPrep Swabstick</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Aqueous CHG 4% w/v applied according to mfr's directions</intervention_name>
    <description>Chlorhexidine gluconate 4% w/v in an aqueous base applied according to mfr's directions. Step 1) 5 ml of Hibiclens applied to a sterile gauze pad. Step 2) Product applied to treatment area on intact skin for 2 minutes. Area dried with sterile towel or sterile gauze. Steps 1 and 2 repeated.</description>
    <arm_group_label>Hibiclens</arm_group_label>
    <other_name>Hibiclens</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sterile swabstick with sterile water (3 @ once)</intervention_name>
    <description>3 sterile swabsticks wetted with sterile water topically applied to intact skin at the same time.</description>
    <arm_group_label>Sterile water swab (3 @ once)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sterile swabstick with sterile water (one-at-a-time)</intervention_name>
    <description>Sterile swabsticks wetted with sterile water topically applied to intact skin one-at-a-time.</description>
    <arm_group_label>Sterile water swabstick (sequential)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Free of dermatoses, cuts, lesions, or other skin disorders on or around test sites;

          -  No exposures to topical or systemic antimicrobials, antibiotics, or steroids (other
             than contraceptives, for 14 day pre-test conditioning period and must agree to abstain
             from these materials until completion of study.

        Exclusion Criteria:

          -  Exposure of test sites to antimicrobial agents, medicated soaps, medicated shampoos,or
             medicated lotions;

          -  Use of biocide-treated pools or hot tubs, use of tanning beds, or sunbathing during
             the 14 day pre-test conditioning period or during the test period;

          -  Exposure of test sites to strong detergent, solvents, or other irritants during the 14
             day pre-test conditioning period or during the test period;

          -  Use of systemic or topical antibiotic medications, steroid medication other than
             contraceptives, or any other product known to affect the normal microbial flora of the
             skin during the 14 day pre-test conditioning period or during the test period.

          -  Known allergies to vinyl, latex (rubber), alcohols, metals, inks or tape adhesives, or
             to common antibacterial agents found in soaps, lotions, or ointments, particularly
             chlorhexidine gluconate, and/or isopropyl alcohol;

          -  A medical diagnosis of a physical condition, such as a current or recent severe
             illness, asthma, diabetes, hepatitis, an organ transplant, any immunocompromised
             conditions such as AIDS (or HIV positive), mitral valve prolapse, or a requirement to
             take antibiotics prior to dental procedures;

          -  Pregnancy, plans to become pregnant within the pre-test and test periods of the study,
             or nursing a child;

          -  Any currently active skin disease or inflammatory skin condition including contact
             dermatitis; Showering or bathing within the 72 hour period prior to sampling;
             Participation in another clinical study in the past 30 days or current participation
             in another clinical study; Any medical condition or use of any medication, that, in
             the opinion of the Study Director, should preclude participation;

          -  Unwillingness to fulfill the performance requirements of the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>M.Hamid Bashir, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical Director</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Microbiotest</name>
      <address>
        <city>Sterling</city>
        <state>Virginia</state>
        <zip>20164</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 26, 2008</study_first_submitted>
  <study_first_submitted_qc>November 26, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 1, 2008</study_first_posted>
  <last_update_submitted>August 10, 2015</last_update_submitted>
  <last_update_submitted_qc>August 10, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 13, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>antimicrobial</keyword>
  <keyword>antisepsis</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chlorhexidine</mesh_term>
    <mesh_term>Chlorhexidine gluconate</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>March 23, 2018</submitted>
    <returned>April 19, 2018</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

